BFM
CDNA icon

Boothbay Fund Management’s CareDx CDNA Stock Holding History

Boothbay Fund Management’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-23,549
Closed -$249K – 1560
2024
Q1 		$249K Buy
+23,549
New +$236K ﹤0.01% 1265
2021
Q1 		– Sell
-6,200
Closed -$449K – 1558
2020
Q4 		$449K Buy
+6,200
New +$359K 0.02% 794

Other funds holding CDNA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Boothbay Fund Management's CDNA Position: Q2 2024 in Review

Boothbay Fund Management sold out of CareDx (CDNA) in Q2 2024, closing a stake of 23,549 shares — an estimated $249K sold.

Boothbay Fund Management first reported a position in CDNA in Q4 2020 and held it in 2 quarters. The position peaked at $449K in Q4 2020. 154 funds tracked by Wall St. Rank hold CDNA as of Q2 2024.

  • Boothbay Fund Management reported no remaining CareDx position as of Q2 2024 after selling out during the quarter.
  • Boothbay Fund Management sold 23,549 CareDx shares in Q2 2024, an estimated $249K.
  • Boothbay Fund Management first reported a position in CareDx in Q4 2020 and held it in 2 quarters.
  • Boothbay Fund Management's CareDx position peaked at $449K in Q4 2020.
  • 154 funds tracked by Wall St. Rank held CareDx as of Q2 2024.

Based on Boothbay Fund Management's 13F filing for Q2 2024, filed 14 Aug 2024.